Metraipolis › archive › dc_381ecfb2f091

Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs — Europe PMC PMID:42306228

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42306228
DOI
10.1210/jendso/bvag121
License (as archived)
solo-consultazione
Archived
2026-10-19T09:25:16.198Z
SHA-256 of the archived text
b68786e1a42524ee0186b82542d07518f707cd0503eebc35ee7bd6b0816a10a0
Stable URL of this page
https://metraipolis.com/documento/dc_381ecfb2f091

How to cite

Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs — Europe PMC PMID:42306228 — Europe PMC (en), https://europepmc.org/article/MED/42306228 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_381ecfb2f091 (Metraipolis archive dc_381ecfb2f091, sha256 b68786e1a42524ee0186b82542d07518f707cd0503eebc35ee7bd6b0816a10a0)
BibTeX
@misc{dc381ecfb2f091,
  title = {Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs — Europe PMC PMID:42306228},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42306228},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_381ecfb2f091; sha256 b68786e1a42524ee0186b82542d07518f707cd0503eebc35ee7bd6b0816a10a0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42306228. Agents can read the archived copy with the MCP tool read_document.